Blue Horizon Enterprise Ltd, 10% Owner at Stoke Therapeutics, Inc. (STOK), sold 3,600,000 shares at $11.60 ($41.8M) on 2024-04-17, disclosed to the SEC on 2024-04-18.
Open-market sale of $41.8M STOK by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |